Diabetic Foot Ulcer Research Study

The goal of this clinical trial is to compare safety and performance of the study device to the current typical NHS standards of care device. The main outcomes it aims to achieve are:Complete wound healing at 12 weeks (100% epithelialised)% Reduction in wound area at 12 weeksParticipants will attend their NHS podiatry clinic appointment as normal and will be assigned either the study device or the current typical NHS standard of care device. Researchers will compare the study device group to the standard group to assess the outcomes mentioned previously.

Inclusion Criteria:Male or female, aged ≥18 years old with a diagnosis of type 1 or type 2 diabetes.New presentation for treatment of a neuropathic, ischaemic or neuro- ischaemic non- infected DFUSubjects must be able to follow verbal and written instructions in EnglishSubjects must have full mental capacity and able to give written informed consent to participation in the trial including medical photography for the purposes of the clinical trial or clinical care.DFU is >10mm2 and <100mm2Exclusion Criteria:Known allergy/hypersensitivity to any ingredient contained in the Keneric healthcare RTD Wound DressingParticipants who will have problems following the protocol, including the offloading system, provided as standard of care, to wear on a daily basisSuspected malignancy in the woundCritical limb ischaemiaPregnant or breastfeeding femalesWomen of childbearing potential and not using a medically accepted form of contraception when sexually active.